Local 12: UC pharmacy resident gives ultimate gift through Be the Match
Matthew Weaver signed up with Be the Match eight years ago, and a few weeks ago he was informed that he was a perfect match for a person with blood cancer in need of his stem cells to survive.
Weaver, a University of Cincinnati James L. Winkle College of Pharmacy alumnus and current pharmacy resident at UC Health, didn't have to go far for the procedure, as the academic health center is one of a few sites across the country that take stem cell donations.
"I think its the greatest gift that I could give this Christmas and hopefully it's a gift to their family to be able to see their loved one a little bit longer," Weaver told Local 12.
Caroline Alquist, MD, associate professor and director of transplantation immunology & therapeutic apheresis at the Hoxworth Blood Center, said the odds of being a stem cell match are slim, but it can make a huge difference.
"Stem cells are like little heat-seeking missiles. They will go to the bone marrow and they will start producing all the healthy cells that that patient needs," said Alquist.
Read or watch the Local 12 story.
Learn more about becoming a potential match.
Featured photo at top of Matthew Weaver courtesy of Local 12.
Related Stories
Ancient warming event hints at potential climate tipping point
August 12, 2026
Researchers say a spike in temperatures during an ice age 304 million years ago could inform what climate scientists are learning about rapidly changing conditions today.
What is a trademark?
August 11, 2026
Sean Owens, an adjunct professor in the Donald P. Klekamp College of Law, discussed trademark law with the Dayton Daily News. Owens is also a partner at intellectual property law firm Wood Herron & Evans in Cincinnati.
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.